Healthcare provider profile · identity verified

Brian C Andrews, M.D

Internal Medicine · MESA, AZ · NPI 1326127473

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	784	260
Levothyroxine Sodium	Levothyroxine Sodium	637	183
Rosuvastatin Calcium	Rosuvastatin Calcium	589	180
Amlodipine Besylate	Amlodipine Besylate	428	140
Losartan Potassium	Losartan Potassium	386	126
Lisinopril	Lisinopril	355	118
Metformin Hcl	Metformin Hcl	299	96
Trazodone Hcl	Trazodone Hcl	271	75
Metformin Hcl Er	Metformin Hcl	265	92
Pantoprazole Sodium	Pantoprazole Sodium	232	74
Tamsulosin Hcl	Tamsulosin Hcl	226	72
Gabapentin	Gabapentin	213	74
Metoprolol Succinate	Metoprolol Succinate	207	69
Escitalopram Oxalate	Escitalopram Oxalate	201	62
Simvastatin	Simvastatin	181	59
Ezetimibe	Ezetimibe	174	53
Omeprazole	Omeprazole	158	58
Ozempic	Semaglutide	153	35
Allopurinol	Allopurinol	152	50
Hydrochlorothiazide	Hydrochlorothiazide	149	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	147	46
Metoprolol Tartrate	Metoprolol Tartrate	137	44
Famotidine	Famotidine	134	43
Duloxetine Hcl	Duloxetine Hcl	126	42
Clopidogrel	Clopidogrel Bisulfate	101	31
Sertraline Hcl	Sertraline Hcl	101	31
Valsartan	Valsartan	100	37
Fenofibrate	Fenofibrate	99	30
Furosemide	Furosemide	98	36
Carvedilol	Carvedilol	88	31
Jardiance	Empagliflozin	87	26
Alprazolam	Alprazolam	83	28
Glimepiride	Glimepiride	81	28
Potassium Chloride	Potassium Chloride	81	28
Synthroid	Levothyroxine Sodium	80	23
Tramadol Hcl	Tramadol Hcl	80	19
Celecoxib	Celecoxib	79	26
Atenolol	Atenolol	78	25
Montelukast Sodium	Montelukast Sodium	74	22
Zolpidem Tartrate	Zolpidem Tartrate	74	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	25
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	72	19
Lorazepam	Lorazepam	69	23
Triamcinolone Acetonide	Triamcinolone Acetonide	69	39
Alendronate Sodium	Alendronate Sodium	68	24
Doxazosin Mesylate	Doxazosin Mesylate	66	19
Prednisone	Prednisone	66	43
Eliquis	Apixaban	63	20
Farxiga	Dapagliflozin Propanediol	62	20
Mirtazapine	Mirtazapine	62	16
Meloxicam	Meloxicam	60	18
Lovastatin	Lovastatin	59	21
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	58	15
Fluticasone Propionate	Fluticasone Propionate	57	21
Pravastatin Sodium	Pravastatin Sodium	56	21
Olmesartan Medoxomil	Olmesartan Medoxomil	54	18
Albuterol Sulfate Hfa	Albuterol Sulfate	52	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	suppressed
Trulicity	Dulaglutide	48	14
Donepezil Hcl	Donepezil Hcl	46	17
Bupropion Xl	Bupropion Hcl	43	12
Ipratropium Bromide	Ipratropium Bromide	43	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	13
Tresiba Flextouch U-100	Insulin Degludec	37	17
Finasteride	Finasteride	36	11
Spironolactone	Spironolactone	35	13
Cephalexin	Cephalexin	34	26
Fluoxetine Hcl	Fluoxetine Hcl	34	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	20
Nifedipine Er	Nifedipine	34	suppressed
Temazepam	Temazepam	34	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	13
Alfuzosin Hcl Er	Alfuzosin Hcl	32	suppressed
Estradiol	Estradiol	30	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	22
Acetaminophen-Codeine	Acetaminophen With Codeine	27	12
Droplet Pen Needle	Pen Needle, Diabetic	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	11
Glipizide	Glipizide	26	suppressed
Azithromycin	Azithromycin	25	25
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	24	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Cefdinir	Cefdinir	23	21
Clonazepam	Clonazepam	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Nystatin	Nystatin	21	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Methylprednisolone	Methylprednisolone	20	18
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ramipril	Ramipril	19	suppressed
Baclofen	Baclofen	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Linzess	Linaclotide	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Livalo	Pitavastatin Calcium	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diazepam	Diazepam	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Primidone	Primidone	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error